Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bashar Attar

Gastroenterology Chicago, IL Medical Doctor

NPI 1790795664 CMS profile 36433

1901 W Harrison St, Chicago, IL 60612

Open in the dashboard

General payments

$120,707

177 records reported · program years 2019–2025

Research payments

$744

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$70 paid to institutions, not to them · program year 2020

Through program year 2025, Bashar Attar of Chicago, IL is reported in the CMS Open Payments database as having received $120,707 across 177 general payments and $744 in research payments paid to them. Separately, studies naming them as principal investigator received $70 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,281 18
2024 General $13,266 21
2023 General $11,090 19
2022 General $11,919 21
2021 General $9,640 15
2020 General $8,919 16
2020 Research $54 2
2019 General $54,592 67
2019 Research $689 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bashar Attar
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Bashar Attar were reported at $11,281. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Bashar Attar Gastroenterology median Middle half National median
2019 $54,592 $417 $126–$1,100 $163
2020 $8,919 $224 $74–$624 $114
2021 $9,640 $352 $106–$1,054 $132
2022 $11,919 $448 $129–$1,270 $149
2023 $11,090 $533 $150–$1,390 $160
2024 $13,266 $605 $160–$1,606 $164
2025 $11,281 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Gilead Sciences, Inc. $118,449 150 payments
  2. Cook Medical LLC $843 13 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $238 2 payments
  4. Ambu A/S $200 1 payment
  5. Eisai Inc. $178 2 payments
  6. Intercept Pharmaceuticals, Inc. $149 1 payment
  7. AbbVie, Inc. $132 2 payments
  8. Allergan Inc. $125 1 payment
  9. Pfizer Inc. $113 1 payment
  10. Olympus America Inc. $98 1 payment
  11. Other $181 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $89,918 42 payments
  2. Travel and Lodging $17,648 61 payments
  3. Consulting Fee $7,690 3 payments
  4. Food and Beverage $5,251 70 payments
  5. Honoraria $200 1 payment
Products named General payments · program years 2019–2025
  1. Epclusa $71,150 95 payments
  2. Hemospray $408 6 payments
  3. STELARA $193 2 payments
  4. Cook Medical Hemostasis $184 3 payments
  5. Lenvima $178 2 payments
  6. INSTINCT $156 3 payments
  7. OCALIVA $149 1 payment
  8. RELISTOR $125 1 payment
  9. ZENPEP $125 1 payment
  10. Vemlidy $121 1 payment
  11. Other $532 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $744 3 payments

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record